-
Glabridin–Gold(I) Complex Enhances Antitumor Immunity
2026-09-20
The reference study develops complex 6d by combining an N-heterocyclic carbene gold(I) center with glabridin to target TrxR and MAPK signaling in liver cancer. Its findings indicate that coordinated redox and immune-microenvironment effects can enhance dendritic-cell maturation, reduce immunosuppressive populations, suppress PD-L1, and promote granzyme B production, while also defining important requirements for mechanistic validation.
-
Tioconazole Workflows for Antifungal Research
2026-09-19
Build more reproducible antifungal assays with Tioconazole, from solvent selection and concentration-response testing to orthogonal ergosterol and membrane-readout validation. This workflow also shows how insights from energy-sensitive DNA-repair research can improve experimental controls without overstating cross-domain evidence.
-
ATG4B Nuclear Translocation and DNA Repair in AML
2026-09-19
The reference study identifies an energy-sensitive ATG4B–PRMT1–MRE11 axis that connects metabolic stress with defective DNA repair and genomic instability in acute myeloid leukemia. Its patient-derived and mouse-model findings suggest that ATG4B inhibition may restrain leukemia progression, while also defining important limits for translating this mechanism beyond AML.
-
lncRNA HITT, ATM, and Cancer Sensitization
2026-09-18
The reference study identifies lncRNA HITT as a direct inhibitor of ATM activation after DNA double-strand breaks. By limiting MRN-dependent ATM recruitment and homologous recombination repair, HITT increases the vulnerability of cancer cells to genotoxic treatment and provides a mechanistic link between noncoding RNA regulation and chemotherapy response.
-
Protease Inhibitor Cocktail for MS-Safe Spike Studies
2026-09-17
Discover how a Protease Inhibitor Cocktail can preserve labile viral and cellular proteins without compromising mass spectrometry. This article connects K4001 sample protection with pH-resolved Lassa virus spike research and practical assay design.
-
Alosetron A3157 for Reliable Cell Assays
2026-09-17
Learn how Alosetron (SKU A3157) can serve as a controlled 5-HT3 receptor pharmacology tool in intestinal proliferation, viability, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical assay controls and the CDC42–YAP–mTOR literature while clearly separating established evidence from research hypotheses.
-
7-dehydro Cholesterol: Applied Research Workflows
2026-09-17
Use 7-dehydro Cholesterol to interrogate DHCR7-dependent sterol flux, UVB-driven vitamin D3 formation, and oxidation-sensitive signaling with controlled, assay-ready workflows. The guide also translates a dhcr7-edited grass carp study into practical controls for lipid, immune, and tissue-response experiments.
-
Disulfiram for Reproducible Cell Viability Assays
2026-09-16
This scenario-based guide explains how Disulfiram, SKU A4015, can support reproducible viability, proliferation, apoptosis, and proteasome studies. It combines practical formulation guidance with evidence from APC-deficient colorectal cancer and established cancer research models.
-
KPT-330 (Selinexor): From Mechanism to Assay Design
2026-09-15
KPT-330 (Selinexor) is a selective CRM1 inhibitor that converts nuclear export biology into a practical framework for cancer research. This guide emphasizes evidence-based assay design, combination testing, and translational interpretation in triple-negative breast cancer models.
-
Capsaicin: TRPV1 and KDM1A Research Guide
2026-09-15
Capsaicin, also called (E)-Capsaicin, is a TRPV1 ion channel activator and a reversible KDM1A/LSD1 inhibitor. Its research utility spans pain signaling pathway studies, inflammation signaling, chronic dermatitis, gastric cancer, and neuronal models, but assay concentration and biological context determine interpretation.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-14
Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from ferroptosis by limiting labile iron. The study connects m6A-dependent RNA regulation with de-SUMOylation, LTF stability, tumor progression, and poor clinical prognosis, providing a mechanistic framework for ferroptosis-sensitizing strategies.
-
Naftifine HCl: Assay Boundaries and Biology
2026-09-14
Naftifine HCl is an allylamine antifungal agent for dissecting sterol-dependent membrane biology. This article connects its mechanism with lessons from WNT5a/GSK3/β-catenin research while defining assay boundaries and practical interpretation standards.
-
PINK1 Deficiency in Bleomycin-Induced Fibrosis
2026-09-13
The reference study identifies PINK1 as more than a driver of canonical mitophagy: in bleomycin-induced lung injury, it suppresses BNIP3- and FUNDC1-mediated mitochondrial clearance. Genetic PINK1 deficiency enhanced this alternative quality-control route, reduced epithelial apoptosis, and attenuated pulmonary fibrosis in mice, providing a mechanistic framework for future pulmonary fibrosis research.
-
Ibuprofen as an Emerging Environmental Contaminant
2026-09-12
Jan-Roblero and Cruz-Maya review how widespread ibuprofen use, environmental persistence, and biological toxicity converge to create an emerging-contaminant problem. The paper’s main practical contribution is to connect evidence on aquatic and soil effects with bacterial biodegradation as a potential, but not yet fully validated, remediation strategy.
-
Dinaciclib Selectively Targets VHL-Deficient ccRCC
2026-09-12
The 2022 Cell Cycle study identified a synthetic-lethal relationship between the CDK inhibitor Dinaciclib and loss of the VHL tumor suppressor in clear cell renal cell carcinoma. Its integrated cell-based, molecular, and orthotopic xenograft experiments support selective activity against proliferating VHL-deficient tumor cells, including CD105-positive and CD105-negative populations, while defining important limits for translation.